3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Sarcoma
12
Lymphoma, Large B-Cell, Diffuse
12
Sarcoma, Ewing
4
Lymphoma, B-Cell
4
Recurrence
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Osteosarcoma
3
Neurofibrosarcoma
3
Lymphoma, Non-Hodgkin
3
Liposarcoma
3
Hodgkin Disease
3
Fibrosarcoma
3
Sarcoma, Synovial
2
Sarcoma, Clear Cell
2
Rhabdomyosarcoma
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Neuroblastoma
2
Nerve Sheath Neoplasms
2
Neoplasms, Germ Cell and Embryonal
2
Lymphoma, Follicular
2
Lymphoma
2
Leiomyosarcoma
2
Histiocytoma, Malignant Fibrous
2
Histiocytoma, Angiomatoid Fibrous
2
Hemangiosarcoma
2
Granuloma, Plasma Cell
2
Desmoplastic Small Round Cell Tumor
2
Dermatofibrosarcoma
2
Chondrosarcoma, Extraskeletal Myxoid
2
Burkitt Lymphoma
2
Interventions
pembrolizumab
12
Pemetrexed
9
Cisplatin
9
Nivolumab
8
Carboplatin
8
Ipilimumab
7
Cyclophosphamide
6
fludarabine
5
durvalumab
4
tremelimumab
2
Radiotherapy, Intensity-Modulated
2
Gemcitabine
2
Cerebral Decortication
2
tocilizumab
1
tislelizumab
1
tazemetostat
1
sotorasib
1
ruxolitinib
1
osimertinib
1
olaparib
1
obinutuzumab
1
naptumomab estafenatox
1
fludarabine phosphate
1
decitabine and cedazuridine drug combination
1
bintrafusp alfa protein, human
1
avelumab
1
atezolizumab
1
Tumor Burden
1
Tablets
1
Saline Solution
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mesothelioma
×
Ifosfamide
×
1 year
×
Clear all
No trials found.